2023-2024

EuroHeartPath

EuroHeartPath will simultaneously conduct 18 pathfinder studies to optimize the personalized early detection, diagnosis, monitoring, and treatment of heart failure, atrial fibrillation, ventricular fibrillation, and coronary disease, with a particular emphasis on prevention.

Project website

About the project

EuroHeartPath aims to transform cardiovascular care in Europe by improving the entire care pathway—from early detection to prevention—for four key conditions: heart failure, atrial fibrillation, ventricular fibrillation, and coronary disease. The project will map current practices in 45 hospitals across 15 countries and conduct 18 pathfinder studies to test the integration of innovations such as AI, digital tools, point-of-care testing, and robotics. By involving patients, cardiologists, and family doctors, EuroHeartPath ensures that solutions are practical and meet real needs. The ultimate goal is to identify and promote best practices that can improve outcomes for patients and strengthen health systems.

EUPHA’s role as a partner

EUPHA will support improvements in care delivery by sharing best practices across countries, helping to ensure patient data is used ethically and safely, and contributing to the planning of how the project’s results can be sustained and used in the long term. EUPHA brings the expertise from within the EUPHA Chronic Diseases section and EUPHA project management to this ambitious initiative.

Financial source

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101194785. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, and Vaccines Europe.

Consortium partners

  • Amarin Pharmaceuticals Ireland Limited

  • ASSISTANCE Publique Hôpitaux de Paris

  • AstraZeneca UK Limited

  • Boston Scientific Nederland B.V.

  • CHARITÉ – Universitätsmedizin Berlin

  • Château Santé

  • Corbotics B.V.

  • Cordys Analytics B.V.

  • DEUTSCHES Herzzentrum München

  • European Pathway Association

  • European Society of Cardiology (ESC)

  • HEART FOR HEALTH ICT B.V.

  • INSEL GRUPPE AG

  • IQVIA Solutions B.V.

  • LONDON School of Economics and Political Science

  • Medtronic GmbH

  • Medtronic Ibérica SA

  • NOVARTIS Pharma B.V.

  • NOVO NORDISK A/S

  • OUTCOMES’10 SL

  • PHILIPS France

  • PHILIPS Medical Systems Nederland B.V.

  • RCF@ICPS

  • SERMAS – Madrid Health Service

  • STICHTING Amsterdam UMC

  • Stichting Sionsberg Netwerk Ziekenhuis

  • STICHTING WONCA Europe

  • TECHNISCHE Universiteit Eindhoven

  • UNIVERSITAIR Medisch Centrum Utrecht

  • UNIVERSITEIT Maastricht

  • VAN VLIET Diagnostics B.V.

  • Viduet Health

  • Vintura B.V.

  • ZEESTA Labs

Other projects

Subscribe to our newsletter